Journal profile
Respirar
ISSN 2953-3414 · Respirar · Argentina
Respirar: diamond open access (no APC); no APC; review about 20 weeks (community reports); 53 articles in 2025.
Scope
Aims, scope and focus
Respirar is published by Respirar. By OpenAlex counts of its recent articles, its largest topics are Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms and COVID-19 Clinical Research Studies, together about 29.1% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Respirar is a free and open access electronic scientific journal. It is an official publication of the Asociación Latinoamericana de Tórax (ALAT). Its objective is to disseminate the scientific work carried out in Latin America in the area of respiratory pathology. This journal is aimed at health professionals.Quarterly: March, June, September and December.- - - - - - - - - -EDITORS IN CHIEF Dr. Francisco Arancibia (Instituto Nacional del Tórax, Santiago de Chile, Chile) https://orcid.org/0000-0001-5429-5420 Dr. Carlos Luna(Hospital de Clínicas, Ciudad Autónoma de Buenos Aires, Argentina) https://orcid.org/0000-0002-9288-096X ASSISTANT EDITORS Dra. Lorena Noriega- Aguirre(Universidad de Panamá, Facultad de Medicina; Ciudad de la salud de la Caja de Seguro Social; Investigadora Nacional I del SNI – SENACYT; Panamá, Panamá) https://orcid.org/0000-0003-1806-9797 Dr. Rogelio Pérez-Padilla (Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Ciudad de México, México) https://orcid.org/0000-0002-1132-5308 Dr. Carlos Arturo Torres-Duque(Centro Internacional de Investigación en Neumología y Salud Respiratoria (CINEUMO); Fundación Neumológica Colombiana; Universidad de La Sabana; Bogotá, Colombia) https://orcid.org/0000-0003-0004-8955 Dr. Gustavo Zabert (Universidad Nacional del Comahue, Facultad de Ciencias Médicas (FACIMED), Rio Negro, Argentina) https://orcid.org/0000-0001-9937-4464 Editorial Coordinator- Editorial Secretary: Lic. Mercedes Cavallero
From the journal's Aims & Scope
Editor-in-chief Francisco ArancibiaPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine12.9%
- Respiratory Support and MechanismsMedicine8.4%
- COVID-19 Clinical Research StudiesMedicine7.9%
- Asthma and respiratory diseasesMedicine7.9%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine7.4%
- Tracheal and airway disordersMedicine4.5%
- Tuberculosis Research and EpidemiologyMedicine4.3%
- Lung Cancer Diagnosis and TreatmentMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SciELOPublisher website
Other: Google Scholar, Crossref, Latindex Catálogo 2.0, MIAR, Núcleo Básico de Revistas Científicas Argentinas, Lilacs, Malena, Dialnet, ROAD
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 3OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0.1OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year (publisher)
- 1Publisher website ·
Articles by year OpenAlex count · 250 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 54 | 54 | 14 |
| 2025 | 53 | 53 | 10 |
| 2024 | 36 | 36 | 7 |
| 2023 | 38 | 38 | 4 |
| 2022 | 61 | 61 | 3 |
| 2021 | 1 | 1 | 0 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 20 weeksLetPub ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–6
- Manuscript length
- ≤ 3,000 words
- Reference style
- Vancouver
- Not considered
- Reviews; Clinical Cases; Images of Respiratory Pathology; Editorials; Letters to the Editor
Article types accepted17, with length limits
- artículos originalesArtículos OriginalesLength not stated
- brief communicationRespirar initially considers the following types of articles: Original Articles; Reviews; Clinical Cases; Images of Respiratory Pathology; Brief Communications;…references ≤ 15
- brief communicationsBrief CommunicationsLength not stated
- casos clínicosCasos clínicosLength not stated
- clinical casesClinical casesLength not stated
- editorialRespirar initially considers the following types of articles: Original Articles; Reviews; Clinical Cases; Images of Respiratory Pathology; Brief Communications;…main text ≤ 1,500 words · references ≤ 20
- editorialesEditorialesLength not stated
- editorialsEditorialsLength not stated
- images of respiratory pathologyImages of respiratory pathologyLength not stated
- letters from readersLetters from ReadersLength not stated
- letters to the editorRespirar initially considers the following types of articles: Original Articles; Reviews; Clinical Cases; Images of Respiratory Pathology; Brief Communications;…main text ≤ 300 words
- original articleRespirar initially considers the following types of articles: Original Articles; Reviews; Clinical Cases; Images of Respiratory Pathology; Brief Communications;…main text ≤ 3,000 words
- original articlesOriginal articlesLength not stated
- recommendations, consensus and guidelinesRecommendations, Consensus and guidelinesLength not stated
- reviewRespirar initially considers the following types of articles: Original Articles; Reviews; Clinical Cases; Images of Respiratory Pathology; Brief Communications;…main text ≤ 3,000 words
- reviewsReviewsLength not stated
- revisionesRevisionesLength not stated
Policy excerpts from the journal's websiteLicense & copyright
- License & copyright Copyright Notice
Creative Commons Attribution (cc-by) license Model summary
When submitting an article, the copyright form will be completed stating the following: By submitting this article, I agree that: 1) I have been sufficiently involved in the research and subsequent data analysis, as well as in the manuscript writing process, to take responsibility for it; 2) This work has not been previously published nor is it being considered for publication in another journal.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Respirar
- Country or region
- Argentina
- Language
- Portuguese, English, Spanish
- ISSN
- 2953-3414
- Society / sponsor
- Asociación Latinoamericana de Tórax
- Latest issue on the website
- Volume 18, Issue 3 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Respirar
How long does peer review take at Respirar?
Authors report an average review time of about 20 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Respirar?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–6; Manuscript length: ≤ 3,000 words; Reference style: Vancouver. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Respirar?
According to LetPub and DOAJ records, Respirar is indexed in DOAJ. The journal's website also lists SciELO; that list has not been checked against each database.
Is Respirar open access, and what is the APC?
Respirar is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .